BioVaxys Technology ( ($TSE:BIOV) ) has shared an update. BioVaxys Technology Corp. announced the conversion of $25,000 in unsecured convertible ...
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") announces the conversion of outstanding unsecured convertible debentures of the Company ("Debentures") ...
Oncolytics Biotech® Inc. (NASDAQ: ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing ...
Evercore's IT hardware and networking analyst Amit Daryanani has Apple at 'outperform' with a share price target of $290, citing the approaching earnings report as the main catalyst.
The latest announcement is out from Shenzhen Dobot Corp Ltd Class H ( ($HK:2432) ). Shenzhen Dobot Corp Ltd announced the grant of 612,825 options ...